Generic antiretroviral drugs are a credible and cheaper alternative to brandsBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f250 (Published 16 January 2013) Cite this as: BMJ 2013;346:f250
Switching from branded to generic antiretroviral drugs for adults with HIV could save the US government nearly $1bn (£0.62bn; €0.75bn) in the first year alone, according to an economic modelling study. Using a mathematical simulation of HIV, the authors compared the costs …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial